Start the conversation
Another inversion deal has come apart at the seams. This morning, the Wall Street Journal reports that Salix Pharmaceuticals Ltd. (Nasdaq: SLXP) and Italian pharmaceutical company Cosmo Pharmaceuticals have terminated their merger agreement due to changes in the "political environment." The companies' merger was originally slated for July. It would have allowed Salix to relocate its operations to Ireland in an effort to reduce its tax burden.